Sulfonylurea derivatives and cancer, friend or foe?

导出 LinkOut

翻译打印收藏纠错

第一作者： Anne M,Hendriks

第一单位： Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

作者： Anne M,Hendriks ^[1] ; Dennis,Schrijnders ^[2] ; Nanne,Kleefstra ^[3] ; Elisabeth G E,de Vries ^[1] ; Henk J G,Bilo ^[4] ; Mathilde,Jalving ^[5] ; Gijs W D,Landman ^[6]

作者单位： Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. ^[1] Langerhans Medical Research Group, Zwolle, the Netherlands; Diabetes Center, Isala Hospital, Zwolle, the Netherlands. ^[2] Langerhans Medical Research Group, Zwolle, the Netherlands. ^[3] Diabetes Center, Isala Hospital, Zwolle, the Netherlands; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. ^[4] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: m.jalving@umcg.nl. ^[5] Langerhans Medical Research Group, Zwolle, the Netherlands; Department of Internal Medicine, Gelre Hospital, Apeldoorn, the Netherlands. ^[6]

关键词 Acetohexamide (PubChem ID: 1989)Cancer Chlorpropamide (PubChem ID: 2727)Glibenclamide Gliclazide Gliclazide (PubChem ID: 3475)Glimepiride (PubChem ID: 3476)Glipizide (PubChem ID: 3478)Glyburide / Glibenclamide (PubChem ID: 3488)Sulfonylurea derivatives Tolazamide (PubChem ID: 5503)Tolbutamide (PubChem ID: 5505)Type 2 diabetes mellitus

主题词动物(Animals);人类(Humans);肿瘤(Neoplasms);危险(Risk);磺酰脲化合物(Sulfonylurea Compounds)

DOI 10.1016/j.ejphar.2019.172598

PMID 31408647

发布时间 2020-02-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交